|
Quotes & Info
|
| PCYC > SEC Filings for PCYC > Form 8-K on 5-Jun-2009 | All Recent SEC Filings |
5-Jun-2009
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard;
On June 2, 2009, Pharmacyclics, Inc. received a confirmation from NASDAQ that its application to be transferred from the NASDAQ Global Market to the NASDAQ Capital Market had been approved. On June 4, 2009, Pharmacyclics commenced trading on the NASDAQ Capital Market. The Company has its same ticker symbol "PCYC". The NASDAQ Capital Market is a continuous trading market that operates in the same manner as the NASDAQ Global Market. The Company meets all of the requirements of the NASDAQ Capital Market and adheres to its standards.
|
|